US Patent 7811566 Antibody-induced apoptosis
Patent 7811566 was granted and assigned to Amgen on October, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 31 Oct, 2023
Golden AI
Edits made to:
Article (+350 characters)
Article
Patent abstract
Anti-Her2 antibodies which induce apoptosis in Her2 expressing cells are disclosed. The antibodies are used to “tag” Her2 overexpressing tumors for elimination by the host immune system. Also disclosed are hybridoma cell lines producing the antibodies, methods for treating cancer using the antibodies, and pharmaceutical compositions.
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07811566 Antibody-induced apoptosis US Patent 7811566 Antibody-induced apoptosis
Infobox
Patent Number
0781156600
Patent Number
781156600
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078115660
Date of Patent
October 12, 2010
0Patent Application Number
119815620
Date Filed
October 30, 2007
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
078115660
Date of Patent
October 12, 2010
0Patent Application Number
119815620
Date Filed
October 30, 2007
0Official Website
Patent Primary Examiner
Edits on 3 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 6 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07811566 Antibody-induced apoptosis
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07811566
Date of patent
October 12, 2010
Patent application number
11981562
Date Filed
October 30, 2007
Patent primary examiner
Find more entities like US Patent 7811566 Antibody-induced apoptosis
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
